Following positive trial data , retatrutide, a new peptide therapy for managing adult-onset metabolic disorder, has secured conditional approval from Great Britain's Drug and Healthcare Agency ( MHRA https://violakgoh483452.blogkoo.com/retatrutide-treatment-peptide-uk-approval-and-launch-60879381